BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25091577)

  • 1. Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.
    Rengucci C; De Maio G; Casadei Gardini A; Zucca M; Scarpi E; Zingaretti C; Foschi G; Tumedei MM; Molinari C; Saragoni L; Puccetti M; Amadori D; Zoli W; Calistri D
    J Exp Clin Cancer Res; 2014 Aug; 33(1):65. PubMed ID: 25091577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes.
    Fiedler D; Hirsch D; El Hajj N; Yang HH; Hu Y; Sticht C; Nanda I; Belle S; Rueschoff J; Lee MP; Ried T; Haaf T; Gaiser T
    Genes Chromosomes Cancer; 2019 Nov; 58(11):783-797. PubMed ID: 31334584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
    Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
    Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
    Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
    Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
    Casadio V; Molinari C; Calistri D; Tebaldi M; Gunelli R; Serra L; Falcini F; Zingaretti C; Silvestrini R; Amadori D; Zoli W
    J Exp Clin Cancer Res; 2013 Nov; 32(1):94. PubMed ID: 24252461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
    Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
    Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
    Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
    Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of
    Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
    Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
    Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
    World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation precedes chromosomal alterations in colorectal cancer development.
    Derks S; Postma C; Moerkerk PT; van den Bosch SM; Carvalho B; Hermsen MA; Giaretti W; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
    Cell Oncol; 2006; 28(5-6):247-57. PubMed ID: 17167178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction.
    Debernardi C; Libera L; Berrino E; Sahnane N; Chiaravalli AM; Laudi C; Berselli M; Sapino A; Sessa F; Venesio T; Furlan D
    Clin Epigenetics; 2021 Aug; 13(1):154. PubMed ID: 34372923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
    Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
    PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.